Screener
Tectonic Therapeutics TECX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 16,160 | 9,709 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ Equity: | ||
| Common stock, $0.0001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 18,830,436 and 18,738,249 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 2 |
| Additional paid-in capital | 478,393 | 474,160 |
| Accumulated other comprehensive loss | — | (96) |
| Accumulated deficit | (247,978) | (222,737) |
| Total stockholders’ equity | 230,417 | 251,329 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's common stock?
- Tectonic Therapeutics (TECX) reported common stock of $2K in Q1 2026.
- How has Tectonic Therapeutics's common stock changed year-over-year?
- Tectonic Therapeutics's common stock decreased by 100.0% year-over-year, from $150M to $2K.
- What is the long-term trend for Tectonic Therapeutics's common stock?
- Over 5 years (2020 to 2025), Tectonic Therapeutics's common stock has grown at a -12.9% compound annual growth rate (CAGR), from $4K to $2K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Tectonic Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude